On June 26, 2025, Autolus Therapeutics plc held its Annual General Meeting where shareholders approved nine resolutions, including adopting the 2024 financial statements and reappointing Ernst & Young LLP as auditors; notable vote counts include 219.8 million for the financial statements and 220.3 million for the auditors.